4Pauwels R, Lofdahl C, Laitinen L, et al. Long term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. N Engl J Med[J]. 1999,340(25):1948.
5Vestbo J,Sorensen T,Lange P,et al. Long - term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: A randomized controlled trial [ J ]. Lancet, 1999,353(9167) :1819.
6The Lung Health Research Group. Effect of inhaler triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease[J]. N Engl J Med,2000,3.43 (26) :1902.
7Burge P,Calverley P, Jones P, et al. Randomized,double blind,placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial [J]. Brit Med J,2000,320(7245) :1297.
8Sin DD, Tu JV. Inhaled corticosteroids and risk and mortality and readmission in elderly patients with chronic obstructive pulmonary disease[ J]. Am J Respir Crit Care Med ,2001,164(4) :580.
二级参考文献20
1Pesci A, Balbi B, Majori M, et al. Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease. Eur Respir J, 1998,12: 380-386.
2Turato G, LuinR, Miniati M, et al. Airway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysema, Am J Respir crit car Med,2002,116105-110.
3Saetta M,Baraldo S,corbino L,et al, CD8+ve cells in the lungs of smokers,with chronic obstructive pulmonary disease[J], Am J Respir Crit care Med,1999,160:711-717.
4O'shoughnessy TC, Ansari TW, Barnes NC, et al. Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T-lymphocytes with FEV1. Am J Respir Crit Care Med,1997,155:852-857.
5Retamales I, Elliott WM, Meshi B, et al. Amplification of inflammation in emphysema and its association with latent adenoviral infection, Am J Respir Crit Care Med, 2001,164:469-473.
6Mikami M ,Llewellyn-Jones CG, Bayley D,et al. The chemotactic activity of sputum from patients with bronchiectasis. Am J Respic Crit Care Med, 1998,157:732-728.
7Fabbri, LM, Romagnoli M, Corbetta L, et al. Differences in airway inflammation in patients with fixed airflow obstruction due to ashma or chronic obstructive pulmonary disease. Am J Respir Crie Care Med,2003,167:418-424.
8Saetta M,Turato G. Mactrelli P,et al. cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med,2001,163:1304-1309.
9Barnes PJ. Mechanisms in COPD:difference from astma. Chest,2000,163:1304-1309.
10Lomas DA,Mahadeva R. Alpha 1 antitrypsin polymerisation and the serpinopathies:pathobiology and prospects for treatment. J Clin Invest,2002,110:1585-1590.
3Celli BR, MacNee W, AST/ERS Task Forea. Standards for the diagnosis and treatment patients with COPD: a summary of the AST/ERS position paper[J]. Eur Respir J, 2004,23 : 932-946.
4林耀广.呼吸内科学[M].北京:中国协和医科大学出版社,2002.417.
5Pauwels R, Lofdahl C, Laitinen L, et al. Long term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. N Engl J Med, 1999,340 ( 25 ) : 1948.
6Vestbo J, Sorensen T, Lange P, et al. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: A rondomize controlled trial. Lancet, 1999,353 (9167 ) : 1819.
7The Lung Health Research Group. Effect of inhaler triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med,2000,343(26) :1902.
8Burge P, Calverley P,Jones P, et al. Randomized, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease:the ISOLDE trial. Brit Med J ,2000,320 (7245) :1297.
9Sin DD, Tu JV, Inhaled corticosteruids and risk and mortality and readmission in elderly patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med,2001,164(4) :580.
